E&S Healthcare promises a healthier life for mankind.
(As of 2017)
In vitro diagnosis using
blood-based single biomarker
The current gold standard of early detection of breast cancer is mammography that has inevitable weak points such as cost, discomfort, and radiation exposure. Besides, an additional examination might be necessary for better diagnosis of dense breasts.
Our breast cancer diagnostic kit, DxMe® BC, measures a specific protein biomarker from the blood by ELISA regardless of breast conditions. It can help detect breast cancer exactly. The accuracy can be maximally enhanced when it is accompanied with mammography.
|Test Format||Sandwich ELISA|
|Brand Name||DxMe® BC|
|Detection Range||0.75 ~ 40 U/ml|
|Tests per kit||96|
|Stability||> 6 months (at 4℃)|